The Asia Pacific Spatial Genomics and Transcriptomics Market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are the reduced cost of next-generation sequencing (NGS) and the increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent.
The market for spatial genomics & transcriptomics is highly consolidated, with key players strategizing to capture majority of the market. Prominent players in the market are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Akoya Biosciences, Inc. (US), PerkinElmer, Inc. (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BGI (China), Miltenyi Biotec (Germany), Bruker (US), PerkinElmer Inc. (US), and Novogene Co., Ltd. (China).
To know about the assumptions considered for the study download the pdf brochure
NanoString Technologies, Inc. (US)
NanoString provides life science tools for translational research. The company is engaged in developing, manufacturing, and commercializing instruments, consumables, and services for simultaneously profiling gene and protein activity from a single tissue sample. In 2019, the company launched the GeoMx Digital Spatial Profiler, enabling highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections. The company operates in the spatial genomics and transcriptomics market through its Product segment.
NanoString achieved its 1,000th placement of the nCounter in 2020; the installed base for Chromium reached 1,105 by Q3 of 2022. Similarly, the company achieved robust placements for its GeoMx Digital Spatial profiler (DSP) systems. The installed base for GeoMx jumped to 255 units in 2021 from 130 units in 2020, showcasing its strength in the instruments business. In February 2021, NanoString launched Whole Transcriptome Atlases, which drove a steady increase in the demand for GeoMx consumables since its launch at the Third Annual Spatial Genomics Summit.
10X Genomics (US)
10x Genomics accounted for the second-largest share in the global spatial genomics and transcriptomics market in 2021. 10x Genomics offers the Visium Spatial platform and consumables such as Visium Spatial Gene Expression assays and Visium mRNA arrays to measure spatial gene expression patterns using high-density DNA barcode sequencing arrays. The company acquired Spatial Transcriptomics (Sweden) in 2018 and entered the spatial genomics and transcriptomics market. Its unique position and leadership in single-cell analysis have paved the way for developing spatial technologies. While the company does not offer spatial transcriptomic solutions at the single-cell level, its expertise offers 10x Genomics a competitive edge in the market.
APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE